This inventor holds 1 USPTO granted patent. Top assignee: Metabasis Therapeutics, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Atul Agurwal: Innovator in Diabetes Treatment
Introduction
Atul Agurwal is a notable inventor based in Hamden, California. He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work focuses on creating novel compounds that can help manage blood glucose levels effectively.
Latest Patents
Atul Agurwal holds a patent for "Heteroaromatic inhibitors of fructose 1,6-bisphosphatase." This patent describes novel FBPase inhibitors that are useful in the treatment of diabetes and other conditions associated with elevated blood glucose. His invention represents a promising advancement in diabetes management.
Career Highlights
Agurwal is associated with Metabasis Therapeutics, Inc., where he applies his expertise in medicinal chemistry and pharmacology. His work at the company has been instrumental in developing therapies aimed at improving the lives of individuals with diabetes.
Collaborations
Some of his notable coworkers include Qun Dang and Srinivas Rao Kasibhatla. Their collaborative efforts contribute to the innovative environment at Metabasis Therapeutics, Inc.
Conclusion
Atul Agurwal's contributions to diabetes treatment through his patent and work at Metabasis Therapeutics, Inc. highlight his role as a significant inventor in the field. His innovative approach continues to pave the way for advancements in managing diabetes effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile